Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization

NCT00555971 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Aspirin Sensitivity

Interventions

DRUG: Omalizumab
DRUG: placebo

Sponsor

David Lang

Collaborators

[object Object]